logo image
search icon
Global Stem Cell Exosome Therapeutic Market

Stem Cell Exosome Therapeutic Market Size, Share & Trends Analysis Report By Source Type (MSC, dendritic cells, umbilical MSC, plasma, and others), By Application, By Region, And By Segment Forecasts, 2023-2031.

Report ID : 1133 | Published : 2023-06-02 | Pages: 180 | Format: PDF/EXCEL

The Stem Cell Exosome Therapeutic Market is valued at 13.69 Million in 2022 and is predicted to reach 59.99 Million by the year 2031 at an 18.05 % CAGR during the forecast period for 2023-2031.

Stem Cell Exosome Therapeutic Market

Exosomes are gaining popularity rapidly as a method to access the therapeutic benefits of stem cells without the complications and difficulties of delivering the cells to patients. Exosomes are sold as diagnostic devices, therapeutic agents, cosmeceuticals, research tools, and much more. The increasing prevalence of autoimmune disease, chronic inflammation, lyme disease, and other chronic degenerative diseases is expected to boost the demand for stem cell exosome therapeutic. Additionally, the emerging research activities in exosome therapeutics are likely to accelerate the market growth in upcoming years. In the last few years, the technologies related to exosomes have been mainly developed and the demand for these technologies are very useful the fields of precision medicine, liquid biopsy, and regenerative medicine. Therefore, this is further projected to enhance the adoption of stem cell exosome therapeutic. Moreover, advancements in exosome isolation and purification techniques and rising healthcare infrastructure are likely to offer lucrative growth opportunities to the global stem cell exosome therapeutic in the next few years.

Market Segmentation

The Stem Cell Exosome Therapeutics Market is a segment based on source type, application, and geography. In terms of source type, the global market is segregated into MSC, dendritic cells, umbilical MSC, plasma, and others. In 2019, the MSC or mesenchymal stem cells segment accounted for a significant share of the global stem cell exosome therapeutics market. Mesenchymal stem cells (MSCs) are one of the most commonly employed cell types as a cell-based therapy for treating human diseases. Mesenchymal stem cells are multipotent, self-renewable, easily manageable, and customarily stretchy in vitro with exceptional genomic stability. It is widely used in the treatment of degenerative and inflammatory disease offspring cells encompassing the transgene after transplantation. Mesenchymal stem cells are used to repair injured organs such as the lung, heart, and kidney. Moreover, the dendritic cells segment is anticipated to grow at the highest CAGR during the forecast period.

Based on the application, the market is segmented into precision medicine, regenerative medicine, and others. Regenerative medicine is the largest contributing category to the global stem cell exosome therapeutic market. Regenerative medicine seeks to enhance the regeneration of tissue and organs that are damaged, malfunctioning and incomplete. Stem cell therapies are promising therapeutics in this field in damaged organs such as the myocardium after heart infarction, spinal cord injury, stroke, damaged liver, and retina diseases. Mesenchymal stem cells represent a promising stem cell population for applications in regenerative medicine. Moreover, stem cell exosome therapeutic has potential applications in precision medicine.

Geographically, the global stem cell exosome therapeutic market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. North America dominates the global stem cell exosome therapeutic market due to the increasing number of autoimmune diseases. Additionally, the emerging research activities required for exosome therapeutics are also projected to boost the market growth. Moreover, the U.S. dominated the regional market owing to the rising preventive expenditure for healthcare and the presence of leading manufacturers of stem cell exosome therapeutics. Europe is anticipated to be the second-largest market for stem cell exosome therapeutic due to the developed healthcare sectors. Furthermore, the Asia Pacific is expected to grow at the highest CAGR with the improved healthcare services, especially in the emerging economies of Asia Pacific.

Competitive Landscape

Some major key players in the Stem Cell Exosome Therapeutic Market:

  • Aegle Therapeutics,
  • Brexogen,
  • Cell Care Therapeutics,
  • CHA Biotech Co., Ltd.,
  • ExoCoBio,
  • Exopharm,
  • NeoProgen, Inc.,
  • OmniSpirant,
  • BrainStorm Cell Therapeutics Inc.,
  • Novadip Biosciences,
  • Unicyte AG,
  • Exogenus Therapeutics,
  • Everkine Corporation,
  • Creative Medical Technology Holdings,
  • Anjarium Biosciences,
  • Capricor Therapeutics, Inc.,
  • Kimera Labs,
  • ReNeuron,
  • Stem Cell Medicine Ltd.,
  • Codiak Biosciencesare

The Stem Cell Exosome Therapeutic Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 13.69 Million

Revenue Forecast In 2031

USD 59.99 Million

Growth Rate CAGR

CAGR of 18.05 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Source Type, By Application

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Aegle Therapeutics, Brexogen, Cell Care Therapeutics, CHA Biotech Co., Ltd., ExoCoBio, Exopharm, NeoProgen, Inc., OmniSpirant, BrainStorm Cell Therapeutics Inc., Novadip Biosciences, Unicyte AG, Exogenus Therapeutics, Everkine Corporation, Creative Medical Technology Holdings, Anjarium Biosciences, Capricor Therapeutics, Inc., Kimera Labs, ReNeuron, Stem Cell Medicine Ltd., Codiak Biosciencesare

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Stem Cell Exosome Therapeutic Market Snapshot

Chapter 4. Global Stem Cell Exosome Therapeutic Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Market Dynamics - Drivers

4.3. Challenges/Restraints

4.4. Market Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

Chapter 5. Market Segmentation 1: Source Type Estimates & Trend Analysis

5.1. Source Type & Market Share, 2019 & 2028

5.2. Market Size (Value) & Forecasts and Trend Analyses, 2019 to 2028 for the following Source Type:

5.2.1. MSC

5.2.2. Dendritic Cells

5.2.3. Umbilical MSC

5.2.4. Plasma

5.2.5. Others

Chapter 6. Market Segmentation 1: Application Estimates & Trend Analysis

6.1. Application & Market Share, 2019 & 2028

6.2. Market Size (Value) & Forecasts and Trend Analyses, 2019 to 2028 for the following Application:

6.2.1. Precision Medicine

6.2.2. Regenerative Medicine

6.2.3. Others

Chapter 7. Stem Cell Exosome Therapeutic Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.1.2. North America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.1.3. North America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by country, 2019-2028

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.2.2. Europe Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.2.3. Europe Stem Cell Exosome Therapeutic Market revenue (US$ Million) by country, 2019-2028

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.3.2. Asia Pacific Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.3.3. Asia Pacific Stem Cell Exosome Therapeutic Market revenue (US$ Million) by country, 2019-2028

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.4.2. Latin America Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.4.3. Latin America Stem Cell Exosome Therapeutic Market revenue (US$ Million) by country, (US$ Million) 2019-2028

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. MEA

7.5.1. MEA Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Source Type, 2019-2028

7.5.2. MEA Stem Cell Exosome Therapeutic Market revenue (US$ Million) estimates and forecasts by Application, 2019-2028

7.5.3. MEA revenue Stem Cell Exosome Therapeutic Market revenue (US$ Million) by country, (US$ Million) 2019-2028

7.5.3.1. South Africa

7.5.3.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Evox Therapeutics

8.2.1.1. Company Overview

8.2.1.2. Financials

8.2.1.3. Source portfolio

8.2.1.4. Business strategy & Recent developments

8.2.2. Aegle Therapeutics

8.2.3. Brexogen

8.2.4. Cell Care Therapeutics

8.2.5. CHA Biotech Co., Ltd.

8.2.6. ExoCoBio

8.2.7. Exopharm

8.2.8. NeoProgen, Inc.

8.2.9. OmniSpirant

8.2.10. BrainStorm Cell Therapeutics Inc.

8.2.11. Novadip Biosciences

8.2.12. Unicyte AG

8.2.13. Exogenus Therapeutics

8.2.14. Everkine Corporation

8.2.15. Creative Medical Technology Holdings

8.2.16. Anjarium Biosciences

8.2.17. Capricor Therapeutics, Inc.

8.2.18. Kimera Labs

8.2.19. ReNeuron

8.2.20. Stem Cell Medicine Ltd.

8.2.21. Codiak Biosciences

8.2.22. Other Prominent Players

Global Stem Cell Exosome Therapeutic Market Segmentation

 Stem Cell Exosome Therapeutic Market

Global Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Source Type

  • MSC
  • Dendritic Cells
  • Umbilical MSC
  • Plasma
  • Others

Global Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Application

  • Precision Medicine
  • Regenerative Medicine
  • Others

Global Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Region

Europe Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • Germany
  • Poland
  • France
  • Italy
  • Spain
  • UK
  • Rest of Europe

North America Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • U.S.
  • Canada

Asia Pacific Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • China
  • India
  • Japan
  • Australia
  • Rest of Asia Pacific

Latin America Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • Brazil
  • Rest of Latin America

Middle East & Africa Stem Cell Exosome Therapeutic Market Outlook (Value (US$ Mn), 2019-2030 By Country

  • South Africa
  • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Stem Cell Exosome Therapeutic Market Size?

The Stem Cell Exosome Therapeutic Market is expected to grow at an 18.05 % CAGR during the forecast period for 2023-2031.

Aegle Therapeutics, Brexogen, Cell Care Therapeutics, CHA Biotech Co., Ltd., ExoCoBio, Exopharm, NeoProgen, Inc., OmniSpirant, BrainStorm Cell Therape

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Biotechnology

Select Licence Type
$4500
$6980
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach